Topics

Companies Related to "Protein Coupled Bile Acid Receptor Pipeline Review 2019" [Most Relevant Company Matches] - Page: 4 RSS

06:32 EST 24th February 2020 | BioPortfolio

Here are the most relevant search results for "Protein Coupled Bile Acid Receptor Pipeline Review 2019" found in our extensive corporate database of over 50,000 company records.

Showing "Protein Coupled Bile Acid Receptor Pipeline Review 2019" Companies 76–100 of 2,500+

Relevant

Myriant Technologies

With a world-renowned team of molecular biologists, engineers and chemists, Myriant utilizes proprietary technology to advance the development of low-cost cellulosic sugars for the sustainable manufacturing of high-value specialty chemicals. The company's D(-) lactic acid started production at commercial scale in June 2008 for use in polylactic acid. Myriant will next begin commercial production o...


Vivacelle Bio, Inc.

Vivacelle Bio, Inc. is a clinical stage biotechnology company that is focused on the discovery of new knowledge in the field of critical care and trauma. Currently, the company’s strategy is to develop and commercialize its discoveries that have led to a pipeline of products that are based on the biophysical properties of phospholipid nanoparticles an...

Athenagen, Inc

Athenagen, Inc., located in South San Francisco, is engaged in the development of small-molecule drugs that act on the nicotinic acetylcholine (nACh) receptor pathway. The company's lead nACh receptor agonists and antagonists are being developed to treat diseases associated with enhanced or impaired angiogenesis and in diseases where cognitive deficit plays a significant role. Athenagen currently ...


Protein’eXpert SA

Protein’eXpert is a Contract Research & Manufacturing Organisation providing tailor-made target & therapeutic recombinant protein services.Protein’eXpert combines advanced molecular engineering with low-to-high-throughput manufacturing technologies to discover, optimize, produce and deliver R&D-compatible volumes of soluble proteins from genomic sequences.We strive to bring cost-effective and ...

Nucleic Acid Purifications (NAP)

Nucleic Acid Purifications (NAP) provides genomic DNA, RNA, mRNA (whole blood and tissue), and plasmid DNA purification, and isolation services for genotyping/expression (microarray) studies.

Transgenomics Incorporated

Cruachem Ltd is a leader in nucleic acid chemistry. We offer custom DNA and RNA oligonucleotides, DNA and RNA synthesis reagents, and contract nucleic acid manufacturing from R & D scale to Kg scale.

ICONIC Protein

ICONIC Protein is one of the fastest-growing brands in the ready-to-drink protein beverage market with a passionate following of health-conscious consumers who have flocked to the brand’s healthy and great-tasting options. Made using dairy protein from grass-fed cows in New Zealand, ICONIC’s ready-to-drink beverage line is hormone, antibiotic and...

Maxygen Incorporated

Headquartered in Redwood City, California, Maxygen is a leading biotechnology company focused on creating novel products using its portfolio of integrated proprietary technologies for a broad range of industries. Maxygen's technologies bring together advances in molecular biology and protein modification to capitalize on the large amount of genetic information generated by genomics. Maxygen curren...

Chesapeake IRB

Chesapeake IRB, an AAHRPP-accredited company, provides independent IRB submission and review services to pharmaceutical, biotech and medical device companies, as well as academic medical centers and hospital systems. Its paperless, cloud-based submission and review platform, CIRBI, leads the field and has set the standard in review turnaround time, quality...

Pierce Biotechnology, Inc.

Pierce Biotechnology, a unit of the Fisher Biosciences group, is one of the first companies researchers turn to when they're conducting protein-studies and related research. Now that the human genome project is completed, researchers are focusing their efforts on the proteins encoded by the mapped genes. Pierce reagents and kits for protein purification, protein detection and quantitation, protein...

Myriant Corporation

Myriant utilizes proprietary technology to provide innovative, performance-based renewable chemicals utilizing low-cost sugars. In December 2010, Myriant broke ground on its 30 million pound commercial succinic acid facility in Lake Providence, Louisiana. The company’s D(-) lactic acid started production at commercial scale in June 2008 for use in pol...

Xenetic Biosciences plc

Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs and vaccines. Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas. Xenetic are also a...

Gout & Uric Acid Education Society

Formed in September 2005, the Gout & Uric Acid Education Society has a comprehensive educational brochure, as well as a user-friendly Web site for patients, caregivers, family members and healthcare providers. For more information about gout and the Gout & Uric Acid Education Society, please visit www.gouteducation.org. Gout Awareness Day is sponsored by Ardea Biosciences, Inc., EnzymeRx, LLC., No...

Unum Therapeutics

Unum Therapeutics uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body’s own immune system to fight cancer. Unum’s lead program, based on its Antibody-Coupled T-cell Receptor (ACTR) technology, is expected to enter Phase I clinical testing in the coming months to assess safety and effi...

Quorum Review

Welcome to Quorum Review Our mission is to safeguard the rights and well-being of research participants while enhancing the clinical research process.

Domain Therapeutics

Domain Therapeutics is a biopharmaceutical company located in Strasbourg, France, dedicated to the discovery and early development of small molecules targeting G-coupled Protein Receptors (GPCRs), one of the best classes of drug targets. Domain Therapeutics is using its innovative and proprietary technology platform DTect-All™ to identify orthosteric and allosteric ligands of GPCRs, incl...

Ascent Scientific

Ascent Scientific offers a range of high quality receptor ligands and synthetic chemistry services at prices so low that as many researchers as possible will be able to afford them. The Low-Cost Ligand range includes receptor ligands and signalling tools in research areas such as glutamate, GABA, ion channels, cannabinoids, opioids, 5-HT and more. The Low-Cost Chemistry Service provid...

Confo Therapeutics

Confo Therapeutics is a VUB-VIB spin-off co-founded in 2015 by VIB and Capricorn Venture Partners with the support of MINTS, PMV, QBIC and V-Bio Ventures. The Company is building a portfolio of first-in-class programs based on its proprietary Confo® technology which makes use of antibody fragments or “Confobodies” to stabilize G-protein couple...

Algenist

A team of biotechnology scientists in San Francisco, California, focused on developing microalgae-based renewable energy solutions, unexpectedly discovered Alguronic Acid, a powerful compound responsible for regenerating and protecting the microalgae cell. When scientifically tested, Alguronic Acid demonstrated significant anti-aging properties, increasing...

Heptares Therapeutics Ltd

Heptares discovers and develops new medicines targeting GPCRs (G-protein-coupled receptors), a super-family of drug targets linked to a wide range of human diseases. We have established R&D collaborations with Shire, Takeda, AstraZeneca, Medimmune, and Novartis Option Fund, and have raised $40 million in venture financing from MVM Life Science Partners, Clarus Ventures, Novartis Venture Fu...

Charities Review Council

The Charities Review Council's mission is to mobilize informed donors and accountable nonprofits to advance the greater good. The Council is an independent resource for people who support charities with financial donations. It is dedicated to empowering donors in making informed and thoughtful giving decisions, so that they can be more effective in helping charities advance their important commu...

Cyrus Biotechnology, Inc.

Cyrus Biotechnology, Inc. is a privately-held biotechnology software company offering protein modeling and design capabilities to the biopharmaceutical, chemical, consumer products and synthetic biology industries. The company offers Cyrus Bench®, a Software-as-a-Service (SaaS) platform for protein structure prediction, modeling, stabilization, and engi...

Biolipox AB (publ.)

Biolipox is a research-intensive pharmaceutical companyThe core of Biolipox's operations is world-leading research on arachidonic acid and its effects on inflammatory diseases - particularly asthma, chronic obstructive pulmonary disease (COPD), rhinitis, pain and arthritis. The discoveries that form the basis of our understanding of the role of arachidonic acid in inflammatory processes were rewar...

BZresources

BZresources regularly manages high volume, complex, Electronically Stored Information (ESI) intensive cases. In each case, we identify, test and implement the most cost effective tools and then customize our processes to reduce review, production and eventual trial costs. Our solutions have been used during BartkoZankel’s cases. We offer clients these...

Paradigm Therapeutics Ltd

Paradigm Therapeutics was founded in 1999 and has established world class target identification and validation capabilities based on gene knock out technology and in vivo pharmacology. The acquisition of Amedis Pharmaceuticals in January 2005 added key medicinal chemistry skills. The combined company has focused on the identification of novel, small molecule tractable targets with defined therapeu...


More From BioPortfolio on "Protein Coupled Bile Acid Receptor Pipeline Review 2019"

Quick Search

Corporate Database Quicklinks